Ultrasound Guided Continuous Suprascapular Nerve Block With Oral Gabapentin For Pain Management In Patients With Frozen Shoulder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The patients will be randomly allocated into two equal groups (each 20 patients) using sealed opaque numbered envelopes: Control Group (C Group) : Patients receive continuous US suprascapular nerve block only. Gabapentin Group (G Group) : Patients receive continuous US suprascapular nerve block with oral gabapentin 300 mg once daily at bed time. Both groups compared as regard: Visual Analogue Scale Range of passive and active movements Patients satisfaction complication related to block The total dose of diclofenac sodium
Epistemonikos ID: 85ac8cb5cdc8135528d27a2278d4c253279261f4
First added on: May 09, 2024